Sydney Medical School, University of Sydney, 90 Palace Street, Petersham, Sydney, NSW, Australia.
Best Pract Res Clin Anaesthesiol. 2013 Mar;27(1):69-84. doi: 10.1016/j.bpa.2013.02.002.
Allogeneic blood transfusion has had a central role in the development and practice of numerous medical and surgical advances. In recent years, transfusion has no longer been regarded as essential for the management of a wide range of diseases and most uncomplicated elective surgeries in well-prepared patients should now be conducted without the use of transfusions. With the exception of chronic haematopoietic deficiencies, the 'transplantation' of allogeneic blood is usually supportive therapy and is generally only required in relationship to complicated major surgery, trauma and until the basic disease processes can be corrected. For most patients it is possible to minimise or avoid blood transfusion by a 'standard of care' management of a patient's own blood by optimising and preserving haematopoietic reserves in conjunction with tolerating the effects of deficiencies. The corollary to avoiding blood transfusion is that potential transfusion hazards need not be considered. This article focusses on the three-pillar matrix of patient blood management. The understanding of basic physiology and pathophysiology is at the core of evidence-based approaches to optimising erythropoiesis, minimising bleeding and tolerating anaemia.
异体输血在许多医学和外科进步的发展和实践中发挥了核心作用。近年来,输血已不再被视为治疗广泛疾病和大多数准备充分的患者的非复杂性择期手术的必要手段,现在应该在不使用输血的情况下进行这些手术。除了慢性造血功能缺陷外,异体血液的“移植”通常是支持性治疗,通常仅在复杂的大手术、创伤以及基本疾病过程得到纠正时才需要。对于大多数患者来说,可以通过优化和保护造血储备,结合耐受缺陷的影响,对患者自身血液进行“常规护理”管理,从而最大限度地减少或避免输血。避免输血的必然结果是不必考虑潜在的输血危害。本文重点介绍患者血液管理的三支柱矩阵。对基本生理学和病理生理学的理解是优化红细胞生成、减少出血和耐受贫血的循证方法的核心。